Yayın:
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study.

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTurhal, N. S.
dc.contributor.authorBaşak Oyan
dc.contributor.authorÖzlem Sönmez
dc.contributor.authorArda Ulaş Mutlu
dc.contributor.authorMuhammed Mustafa Atçı
dc.contributor.authorİrem Öner
dc.contributor.authorHavva Yeşil Çınkır
dc.contributor.authorMelek Karakurt Eryılmaz
dc.contributor.authorOnur Yazdan Balçık
dc.contributor.authorNail Paksoy
dc.contributor.authorDerya Kıvrak Salim
dc.contributor.authorMiraç Özen
dc.contributor.authorMelike Özçelik
dc.contributor.authorAli Arıcan
dc.contributor.authorAli̇ İnal
dc.contributor.authorBaran Akagündüz
dc.contributor.authorDinçer Aydın
dc.contributor.authorLeyla Özer
dc.contributor.authorN. S. Turhal
dc.contributor.authorAhmet Gülmez
dc.contributor.orcid0000-0002-1686-1628
dc.contributor.orcid0000-0002-6656-9000
dc.contributor.orcid0000-0001-7499-7155
dc.contributor.orcid0000-0002-1300-3695
dc.contributor.orcid0000-0001-9486-6187
dc.contributor.orcid0000-0002-7870-8741
dc.contributor.orcid0000-0003-2597-5931
dc.contributor.orcid0000-0002-3386-2075
dc.contributor.orcid0000-0003-4636-2595
dc.contributor.orcid0000-0003-4107-3460
dc.contributor.orcid0000-0002-1934-0190
dc.contributor.orcid0000-0003-0406-715X
dc.contributor.orcid0000-0002-6099-2000
dc.contributor.orcid0000-0002-0690-2529
dc.contributor.orcid0000-0002-4979-3123
dc.contributor.orcid0000-0002-7433-3591
dc.contributor.orcid0000-0002-1430-2662
dc.contributor.orcid0000-0002-1013-5676
dc.contributor.orcid0000-0002-3353-344X
dc.date.accessioned2025-11-13T19:38:43Z
dc.date.issued2022-01-19
dc.identifier.doihttps://doi.org/10.1200/jco.2022.40.4_suppl.202
dc.identifier.endpage202
dc.identifier.issn0732-183X
dc.identifier.issue4_suppl
dc.identifier.openalexW4206559885
dc.identifier.startpage202
dc.identifier.urihttps://hdl.handle.net/11421/11434
dc.identifier.urihttps://doi.org/10.1200/jco.2022.40.4_suppl.202
dc.identifier.volume40
dc.language.isoen
dc.relation.ispartofJournal of Clinical Oncology
dc.rightsrestrictedAccess
dc.subjectMedicine
dc.subjectRegorafenib
dc.subjectColorectal cancer
dc.subjectInternal medicine
dc.subjectChemotherapy
dc.subjectFluorouracil
dc.subjectOncology
dc.subjectRegimen
dc.subjectChemotherapy regimen
dc.subjectProportional hazards model
dc.subjectOxaliplatin
dc.subjectCancer
dc.subject.sdg3
dc.titleEfficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study.
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5064011743

Dosyalar

Koleksiyonlar

Publications